Immunotherapies for cancer—treatments that prime the immune system to attack tumors—are valuable weapons in the anti-cancer arsenal. But some cancers are more difficult to target with this strategy than others. Today, ...
Aug 17, 2020
0
478
Researchers at UConn's Center of Excellence in Vaccine Research (CEVR) have made a breakthrough in vaccine development for a common and difficult to treat pneumonia-causing pathogen. Their research was recently published ...
Jun 17, 2020
0
63
A single injection of a new gene therapy protected mice from the effects of sarin and other deadly chemical warfare agents for months, new work that could not only help defend soldiers and civilians in war zones, but also ...
Jan 23, 2020
0
419
Allergic reactions in the skin can be caused by many different chemical compounds in creams, cosmetics, and other consumer products, but how they trigger the reaction has remained somewhat mysterious.
Jan 3, 2020
2
113
A metabolic imbalance in some cancer patients following treatment with a checkpoint inhibitor drug, nivolumab, is associated with resistance to the immunotherapy agent and shorter survival, report scientists from Dana-Farber ...
Sep 25, 2019
0
41
Pancreatic cancer is especially challenging to treat—only eight percent of patients are still alive five years after diagnosis. Chemotherapy and radiation therapy are of limited benefit, and even immunotherapy—which revolutionized ...
Jul 3, 2019
0
9
New research from the laboratory of cancer scientist Dr. Tak Mak, renowned for cloning the human T-cell receptor, has demonstrated that immune cells make brain chemicals to fight off infections.
Feb 7, 2019
0
1144
In a new study published June 7th, 2018 in PLOS Genetics, Christine Ambrosone of Roswell Park Comprehensive Cancer Center and colleagues identified a genetic difference between people with African and European ancestry that ...
Jun 7, 2018
0
32
Chronic inflammation caused by disease or exposure to dangerous chemicals has long been linked to cancer, but exactly how this process takes place has remained unclear.
Aug 7, 2015
0
4495
Rutgers University scientists have determined the structure of a hepatitis C surface protein, a finding that could assist in the development of a vaccine to halt the spread of the the deadly disease that has infected 3.2 ...
Feb 19, 2014
0
0
